Biotech

All Articles

AZ licenses discarded uncommon condition drug to Monopar Therapeutics

.Monopar Therapeutics is actually recouping a drug coming from the dump of AstraZeneca's uncommon di...

Arcus' brand-new HIF-2a data in renal cancer cells hint at possible advantage over Merck's Welireg, professionals state

.Along with brand-new information out on Arcus Biosciences' speculative HIF-2a inhibitor, one group ...

Roche wagers around $1B to extend Dyno genetics therapy delivery treaty

.After developing a gene therapy alliance with Dyno Rehabs in 2020, Roche is back for even more.In a...

Lundbeck slashes value of $250M Abide buyout after ache obstacle

.Lundbeck is lowering the book value of its $250 thousand Abide Therapeutics buyout in response to p...

Real- World Data Meets Professional Test Design: Improving Procedures and Website Selection

.The integration of real-world data (RWD) into procedure feasibility and website assortment has beco...

Where are they now? Overtaking previous Brutal 15 guest of honors

.At this year's Fierce Biotech Peak in Boston ma, we overtook forerunners in the biotech sector who ...

Merck purchases preclinical DNA biotech for $1.3 B biobucks

.Merck &amp Co. is setting down $30 million beforehand to acquire Yale spinout Modifi Biosciences, a...

Radiopharma Alpha-9 increases $175M collection C to cash clinical press

.Alpha-9 Oncology has raised a $175 thousand series C cycle to bankroll its own clinical-stage radio...

Ocuphire to enhance into genetics treatment biotech through Opus buyout

.Eye medication maker Ocuphire Pharma is acquiring gene therapy creator Opus Genetics in an all-stoc...

Roche culls cough candidate, pivots KRAS system in Q3 upgrade

.Roche's persistent coughing plan has actually sputtered to a stop. The drugmaker, which axed the pl...